DGAP-News: Biotest AG / Key word(s): Miscellaneous
09.04.2019 / 07:00
The issuer is solely responsible for the content of this announcement.
Biotest AG opens ninth plasma collection centre in Hungary
– 21 plasma collection centres in Europe to ensure long-term plasma supply
Dreieich, 9 April 2019. Biotest received an operating permit for its ninth plasma collection centre in Hungary from the country’s national public health authority OTH. The centre is located in the capital Budapest and is one of Europe’s most modern ones. Thus, the company is further expanding its plasma collection capacity and is safeguarding the plasma supply to future growth.
The first plasma collection centre in Budapest was opened in 2009 by Plazmaszolgálat Kft., a 100% subsidiary of Biotest AG. “We are very pleased about the opening of another donor centre in Hungary. In Budapest, we create more than 25 highly qualified jobs. I would like to express my gratitude to all donors of plasma, who enable us to produce life-saving medicines out of it”, stated Dr Martin Reinecke, Senior Vice President Global Plasma Alliances and Protein Supply of Biotest AG.
The collected plasma is processed only by Biotest AG at Dreieich, Germany. Regular audits in Hungary ensure that the strict legal and internal quality requirements are met.
About human blood plasma
Biotest AG, Landsteinerstr. 5, 63303 Dreieich, Germany, www.biotest.com
Ordinary shares: securities’ ID No. 522720; ISIN DE0005227201
09.04.2019 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Phone:||0 61 03 – 8 01-0|
|Fax:||0 61 03 – 8 01-150|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||797035|
|End of News||DGAP News Service|